[ET Net News Agency, 9 June 2021] Credit Suisse raised its target price for MicroPort
Scientific (00853) to HK$60 from HK$40 and upgraded its rating to "neutral" from
"underperform" as it sees catalysts ahead across subsidiaries.
The research house expects the potential listing of the surgical robot business to also
fare well in the capital markets, which could be an added boost to MicroPort's valuation
and account for the completion of new capital contribution to Medbot subsidiary that
reached a post-money valuation of Rmb25bn.
Credit Suisse revised its FY2021/22/23 EPS forecasts by 2%/8%/(51)% due to revised
segment revenue forecasts. (KL)